Не колу разливаем. Россия одной из первых в мире сделала эффективную вакцину от ковида — но на Западе «Спутник V» так и не получил признания. Расследование «Медузы»
Meduza,
Данное сообщение (материал) создано и (или) распространено иностранным средством массовой информации, выполняющим функции иностра…
BEST OF THE WEB: Russia's COVID coup d'etat
Sign of the Times,
One can't help but feel a certain kinship with Mikhail Delyagin, the State Duma deputy who perfectly captured the zeitgeist of…
Two years of COVID-19: Key milestones in the pandemic
World Economic Forum,
Two years after the first case of COVID-19 was reported, we look back at key milestones in the spread of the coronavirus…
В The Lancet опубликовали результаты исследования вакцины «Спутник Лайт»
Meduza,
Данное сообщение (материал) создано и (или) распространено иностранным средством массовой информации, выполняющим функции иностра…
New CDC Covid-19 Warnings: Avoid Travel To Russia, Belgium, Slovakia, Burkina Faso
Forbes,
Even if you can see Russia from your house, you may not want to go there right now.
Эксперт рассказала, переносится ли «КовиВак» легче «Спутника V»
Medportal,
Автор: 1 минута Чтобы ответить на вопрос о том, насколько эффективна любая вакцина, стоит прежде всего обратиться к научным источ…
Производство "КовиВака" временно приостановили. Почему? - BBC News Русская служба
BBC News,
14 минут назад Автор фото, Elena Afonina/TASS Выпуск вакцины "КовиВак", с самого начала ее применения пользовавшейся большим спро…
How not to run a vaccine clinical trial – The Sputnik case study
Mail & Guardian,
This story is published as part of a series investigating how the Sputnik V vaccine compares to other Covid-19 preventatives.
Evidence Suggests Russia’s Sputnik V COVID Vaccine is Safe and Effective
The National Interest,
Russia was the first country to register a COVID vaccine, with its health ministry giving emergency approval to the Sputnik V…
Growing evidence suggests Russia's Sputnik V COVID vaccine is safe and very effective, but questions remain
MedicalXpress,
Russia was the first country to register a COVID vaccine, with its health ministry giving emergency approval to the Sputnik V…
Growing evidence suggests Russia's Sputnik V COVID vaccine is safe and very effective. But questions about the data remain
The Pioneer,
Russia was the first country to register a COVID vaccine, with its health ministry giving emergency approval to the Sputnik V…
Is Sputnik V Covid-19 vaccine safe and effective?
The Deccan Herald,
By Megan Steain and Jamie Triccas for The Conversation, Russia was the first country to register a Covid vaccine, with its…
Growing evidence suggests Russia's Sputnik V COVID vaccine is safe and very effective. But questions about the data remain
Tribune India,
Sydney, July 28 Russia was the first country to register a COVID vaccine, with its health ministry giving emergency approval to…
Growing evidence suggests Russia’s Sputnik V COVID vaccine is safe and very effective. But questions about the data remain
The Week (India),
By Megan Steain and Jamie Triccas, University of Sydney Sydney, Jul 28 (The Conversation) Russia was the first country to…
Growing evidence suggests Russia’s Sputnik V COVID vaccine is safe and very effective. But questions about the data remain
Outlook India,
By Megan Steain and Jamie Triccas, University of Sydney Sydney, Jul 28 (The Conversation) Russia was the first country to…
World News | Growing Evidence Suggests Russia's Sputnik V COVID Vaccine is Safe and Very Effective. But Questions About the Data Remain | LatestLY
Latestly,
Sydney, Jul 28 (The Conversation) Russia was the first country to register a COVID vaccine, with its health ministry giving…
Growing evidence suggests Russia’s Sputnik V COVID vaccine is safe and very effective. But questions about the data remain
Devdiscourse,
By Megan Steain and Jamie Triccas, University of Sydney Sydney, Jul 28 (The Conversation) Russia was the first country to…
Growing evidence suggests Russia’s Sputnik V COVID vaccine is safe and very effective
Mirage News,
Russia was the first country to register a COVID vaccine, with its health ministry giving emergency approval to the Sputnik V…
Growing evidence suggests Russia's Sputnik V COVID vaccine is safe and very effective. But questions about the data remain
The Conversation,
Russia was the first country to register a COVID vaccine, with its health ministry giving emergency approval to the Sputnik V…
Growing evidence suggests Russia's Sputnik V COVID vaccine is safe and very effective. But questions about the data remain
Newsbreak,
Russia was the first country to register a COVID vaccine, with its health ministry giving emergency approval to the Sputnik V…
Многие не хотят делать прививку, потому что боятся «побочек». Разбираемся, какими они бывают у «Спутника V», как часто встречаются — и насколько опасны
Meduza,
Данное сообщение (материал) создано и (или) распространено иностранным средством массовой информации, выполняющим функции иностра…
Che fine ha fatto Sputnik V - Il Post
Il Post,
Sputnik V, il vaccino contro il coronavirus sviluppato in Russia, era stato accolto con qualche perplessità e scetticismo dagli…
Combinar vacunas frente al Covid puede aumentar la respuesta del sistema: Científicos
El Imparcial,
Los datos preliminares del estudio CombiVacS arrojan luz sobre las características diferenciales que puede aportar una…
Combinar vacunas frente al SARS-Cov-2 puede aumentar la respuesta del sistema inmune
The Conversation,
Cuando hace un par de meses la administración de la vacuna ChAdOx1-S de AstraZeneca (Vaxzebria) trajo consigo algunos efectos…
„Was, wenn beim Sputnik V das Vektorvirus repliziert?“
Deutsches Ärzteblatt,
Berlin Die Diskussionen um den Impfstoff Sputnik V reien nicht ab. Nachdem erst vor einigen Wochen bekannt wurde, dass die…
СМИ узнали об отказе в Минздраве от испытаний «Спутника V» с AstraZeneca
RBC Daily,
Комитет Минздрава выступил против испытаний связки вакцин AstraZeneca и «Спутник V» на людях, узнал «Фармвестник».
Сколько миллионов жителей России получат «слабую» вакцину и кто в этом виноват?
Naked Science,
Как раньше уже не будет На сегодня от коронавирусной эпидемии в России погибли около полумиллиона человек (вопреки заявлениям вла…
Covid-19 vaccines: A stamp of approval from a journal isn't a substitute for regulator scrutiny
Dailyhunt,
Regulatory output is far more transparent and accurate than peer review. A superficial reading of the history of vaccination…
Covid-19 vaccines: A stamp of approval from a journal isn’t a substitute for regulator scrutiny
Scroll India ,
A superficial reading of the history of vaccination might lead you to believe that it is simple.
COVID vaccines: the danger of journals being seen as substitute regulators
Outlook India,
By Christoffer van Tulleken, UCL London, May 21 (The Conversation) A superficial reading of the history of vaccination might…
The Sputnik V COVID vaccine and the two significant risks untested vaccines present.
infosurhoy,
A superficial reading of the history of vaccination might lead you to believe that it is simple.
The Sputnik V COVID vaccine and the two significant risks untested vaccines present
MedicalXpress,
A superficial reading of the history of vaccination might lead you to believe that it is simple.
News story from Big News Network on Wednesday 19 May 2021
Big News Network,
COVID vaccines: the danger of journals being seen as substitute regulators
Yahoo! News,
A superficial reading of the history of vaccination might lead you to believe that it is simple.
MIL-OSI Global: COVID vaccines: the danger of journals being seen as substitute regulators
Foreign Affairs New Zealand,
– By Christoffer van Tulleken, Honorary Associate Professor, UCL A superficial reading of the history of vaccination might lead…
COVID vaccines: the danger of journals being seen as substitute regulators
Yahoo! News,
A superficial reading of the history of vaccination might lead you to believe that it is simple.
COVID vaccines: the danger of journals being seen as substitute regulators
The Conversation,
A superficial reading of the history of vaccination might lead you to believe that it is simple.
Создатели "Спутник-V" пригрозили судом регулятору Бразилии за дезинформацию - BBC News Русская служба
BBC News,
9 минут назад Автор фото, Vitaly Nevar/TASS Разрабочики российской вакцины от коронавируса "Спутник-V" пригрозили подать в суд на…
Sputnik V: o que se sabe sobre a vacina russa que será tema de reunião da Anvisa nesta segunda
UOL,
Imunizante já foi autorizado em 61 países, segundo o instituto Gamaleya, responsável por seu desenvolvimento, mas ainda não foi…
Sputnik V: o que se sabe sobre a vacina russa que será tema de reunião da Anvisa nesta segunda
Yahoo! News Brazil,
O uso da Sputnik já foi autorizado em 51 países, que reúnem uma população somada de 1,3 bilhões de pessoas A Agência Nacional…
O que se sabe sobre a Sputnik V, a vacina russa que será tema de reunião da Anvisa nesta segunda - BBC News Brasil
BBC News,
Rafael Barifouse Da BBC News Brasil em São Paulo 23 janeiro 2021 Atualizado Há 8 minutos Crédito, Reuters A Agência Nacional de…
O que se sabe sobre a Sputnik V, a vacina russa que tem efetividade de 97,6%, de acordo com novo estudo - BBC News Brasil
BBC News,
Rafael Barifouse Da BBC News Brasil em São Paulo 23 janeiro 2021 Atualizado Há 10 minutos Crédito, Reuters A vacina russa…
«ЭпиВакКорона» глазами участников клинических испытаний иученых-биологов • Библиотека
elementy.ru,
Денис Лагуткин, молекулярный биолог, участник IIIфазы клинических испытаний «ЭпиВакКороны», Андрей Криницкий, администратор групп…
COVID-19 in 2020 — a timeline of the coronavirus outbreak
Devex International Development,
A health worker receives a COVID-19 immunization in British Columbia, Canada, on Dec.
Timeline Of Russian Sputnik V Covid-19 Vaccine, Approved For Emergency Use In India
Swarajya,
Russia's Covid-19 vaccine is the world’s first to be registered based on the human adenoviral vector-based platform.
News story from Sciences et Avenir on Friday 09 April 2021
Sciences et Avenir,
Sputnik V y CoronaVac son dos opciones de vacuna para Panamá | La Prensa Panamá
La Prensa (PAN),
La carrera global por lograr la mayor cantidad de vacunas contra la enfermedad Covid-19 en poco tiempo es, posiblemente, una de…
Covid-19-Impfung: Das können die Corona-Impfstoffe leisten
Spektrum,
Covid-19-Impfung: Das können die Corona-Impfstoffe leisten Bisher haben vier Corona-Impfstoffe eine Zulassung in der EU.
Covid-19 news archive: Pfizer vaccine is 95 per cent effective
New Scientist,
A BioNTech laboratory in Mainz, Germany 18 November Pfizer vaccine is 95 per cent effective overall and protects 94 per cent of…
Wie gut ist der Corona-Impfstoff aus Russland?
MSN,
Für Russlands Präsidenten Wladimir Putin ist der in seinem Land entwickelte Corona-Impfstoff der beste.
Sputnik V: Wie gut ist der Corona-Impfstoff aus Russland? - WELT
Die Welt,
Nach Diskussionen um AstraZeneca gibt es mit Sputnik V wieder einen Impfstoff, der für Wirbel sorgen könnte.
So gut ist „Sputnik V“
ORF.at,
Die Europäische Arzneimittelbehörde (EMA) prüft gerade den russischen Coronavirus-Impfstoff „Sputnik V“.
So gut ist Sputnik V
ORF.at,
Die Europäische Arzneimittel-Agentur (EMA) prüft gerade den russischen Coronavirus-Impfstoff Sputnik V.
Sputnik V: o que se sabe sobre a vacina russa que teve milhões de doses compradas pelo governo federal e Estados do NE
Yahoo! News Brazil,
O uso da Sputnik já foi autorizado em 51 países, que reúnem uma população somada de 1,3 bilhões de pessoas Foi anunciada no sábad…
Делать ли прививку от коронавируса тем, кто уже переболел? Отвечаем коротко, но не одним словом
Meduza,
1 Что случилось? В России вакцина от коронавируса, кажется, доступна сейчас если не всем желающим, то все большему их количеству.
AstraZeneca, Biontech/Pfizer, Moderna: Das können die Corona-Impfstoffe leisten
Spektrum,
AstraZeneca, Biontech/Pfizer, Moderna: Das können die Corona-Impfstoffe leisten Bislang haben drei Corona-Impfstoffe eine…
U.S. has secured 200 million more doses of COVID-19 vaccines
National Geographic,
U.S. President Joe Biden says his administration has procured 200 million more doses of the Moderna and Pfizer-BioNTech vaccines.
Хочу сделать прививку — надо ли бояться? И как не допустить ошибок?
Naked Science,
1. Большинство жителей России не хотят вакцинироваться. Почему? Причин две: самоуспокоенность и инстинктивное опасение всего ново…
It's time to trust China's and Russia's Covid vaccines
Dailyhunt,
THEY, TOO, WORK, AND THEY CAN HELP FILL SHORTAGES EVERYWHERE. While the richest countries in the world are grappling with…
It’s time to trust China, Russia’s Covid-19 vaccines
The Deccan Herald,
THEY, TOO, WORK, AND THEY CAN HELP FILL SHORTAGES EVERYWHERE. While the richest countries in the world are grappling with…
Johnson
National Geographic,
Johnson
Opinion | It’s Time to Trust China’s and Russia’s Vaccines
New York Times,
They, too, work, and they can help fill shortages everywhere. Achal Prabhala and Chee Yoke Ling Mr.
Interim Analysis Suggests “Sputnik” Vaccine Has Efficacy Rate of 91.6%
Technology Networks,
An interim analysis of data from the phase 3 trial of the COVID-19 vaccine from Russia (Gam-COVID-Vac) suggests that a two-dose…
Covid, quello che sappiamo sull'efficacia del vaccino russo Sputnik V - Galileo
Galileonet,
Una delle riviste mediche più autorevoli al mondo,Lancet, ha appena pubblicato i risultati preliminari di un’analisi ad interim…
News story from Le Monde on Wednesday 03 February 2021
Le Monde,
News story from Daily Mail on Wednesday 03 February 2021
Daily Mail,
Two-dose regimen of adenovirus-based vaccine offers 91.6% efficacy against COVID-19
The Medical News,
An interim analysis of data from the phase 3 trial of the COVID-19 vaccine from Russia (Gam-COVID-Vac) suggests that a two-dose…
Шах и мат критикам российской вакцины: эффективность «Спутника V» подтверждена публикацией в журнале The Lancet
MSN,
2 февраля 2021 года в одном из самых авторитетных международных научно-медицинских журналов The Lancet появилась очередная публик…
Study reports preliminary efficacy and safety results from interim analysis of Russian COVID-19 phase 3 vaccine trial
Newswise,
Interim analysis from phase 3 trial of nearly 20,000 participants suggests efficacy of two-dose regimen of the adenovirus-based…
Sputnik V: Hungary is first EU country to use Russian Covid vaccine
Express Informer,
German Chancellor Angela Merkel said ‘all vaccines are welcome’ today as she praised Russia’s Sputnik V jab.
Preliminary efficacy and safety results from the Russian COVID-19 vaccine phase 3 trial BioNews Central
Bionewscentral,
Preliminary efficacy and safety results from the Russian COVID-19 vaccine phase 3 trial.
The Lancet: Study reports preliminary efficacy and safety results from interim analysis of Russian COVID-19 phase 3 vaccine trial | Scienmag: Latest Science and Health News
ScienMag,
Interim analysis from phase 3 trial of nearly 20,000 participants suggests efficacy of two-dose regimen of the adenovirus-based…
Sputnik V: Hungary becomes first EU country to adopt Russia's vaccine - NewsyPeople
NewsyPeople,
Hungary has become the first country in the European Union to adopt Russia‘s ‘high efficacy’ Sputnik V coronavirus vaccine.
Hungary becomes first EU country to adopt Russia's Sputnik V vaccine as country's minister slams Brussels' 'failed' bid to buy jabs
This is Money,
The first batch of 40,000 Sputnik V arrived from Russia in Hungary on Tuesday EU 'centralised vaccine procurement has failed,…
News story from Daily Mail on Tuesday 02 February 2021
Daily Mail,
Study reports preliminary efficacy and safety results from interim analysis of Russian COVID-19 phase 3 vaccine trial | sciencenewsnet.in
Sciencenewsnet.in,
Post Views: 4 Interim analysis from phase 3 trial of nearly 20,000 participants suggests efficacy of two-dose regimen of the…
Russia's Sputnik V vaccine appears safe, effective: study
CTV News,
MOSCOW -- Russian scientists say the country's Sputnik V vaccine appears safe and effective against COVID-19, according to…
Russia's controversial Covid jab is 92% efffective, major study finds
The Amed Post,
Russia’s controversial coronavirus vaccine is 92 per cent effective at blocking symptomatic illness, early trial results…
Russia’s controversial Covid jab is 92% efffective, major study finds
Express Informer,
Russia’s controversial coronavirus vaccine is 92 per cent effective at blocking symptomatic illness, early trial results…
In phase 3 trials, Sputnik V showed efficacy of 91.6%: Lancet
CNBC TV18,
Among adverse events, 94 percent were mild and included flu-like symptoms, reactions in the site of the vaccine, headache and…
News story from Daily Mail on Tuesday 02 February 2021
Daily Mail,
Russia's controversial Covid jab is 92% effective: 'Sputnik V' vaccine which Vladimir Putin approved six months ago is safe and prevents almost all deaths and hospital admissions, major trial finds
Newsbreak,
Russia's controversial coronavirus vaccine is 92 per cent effective at blocking symptomatic illness, early trial results…
Russia's controversial Covid jab is 92% efffective, major study finds
Google News,
Russia's controversial coronavirus vaccine is 92 per cent effective at blocking symptomatic illness, early trial results…
Sputnik V: Russischer Covid-19-Impfstoff zu mehr als 90 Prozent wirksam
Spektrum,
Sputnik V: Russischer Covid-19-Impfstoff zu mehr als 90 Prozent wirksam Der Impfstoffkandidat Sputnik V aus Russland schützt zu…
Kent Covid variant may mutate to look more like South African strain
Google News,
The Kent Covid variant has started to mutate further to become more like the one that evolved in South Africa in what…
The Lancet: Study reports preliminary efficacy and safety results from interim analysis of Russian COVID-19 phase 3 vaccine trial
EurekAlert!,
Interim analysis from phase 3 trial of nearly 20,000 participants suggests efficacy of two-dose regimen of the adenovirus-based…
Russia's COVID-19 Vaccine 91.6% Effective, Studies Show
Medscape,
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
Johnson
National Geographic,
Johnson
La Embajada de Rusia en México desmiente mitos y 'fake news' sobre la vacuna Sputnik V
Sputnik News,
© Foto : Pixabay/JoeBamz Después de que el 25 de enero los presidentes de México y Rusia, Andrés Manuel López Obrador y Vladímir…
La rusofobia en México que desató la vacuna Sputnik V (aunque el problema viene de tiempo atrás)
RT Network,
Javier Buenrostro Publicado: 28 ene 2021 17:51 GMT Este lunes se dio a conocer que los mandatarios de México y Rusia…
La Embajada de Rusia en México asegura que la vacuna Sputnik V es segura
MSN,
La Embajada de Rusia en México rechazó las críticas contra la vacuna Sputnik V y salió a defender su efectividad.
News story from Le Parisien on Thursday 28 January 2021
Le Parisien,
Will combining Oxford's vaccine with Russia's Sputnik V make it more effective?
Dailyhunt,
When the efficacy of the Oxford/AstraZeneca vaccine was announced in late 2020, there was some confusion.
Will combining Oxford's vaccine with Russia's Sputnik V make it more effective?
Yahoo! News,
When the efficacy of the Oxford/AstraZeneca vaccine was announced in late 2020, there was some confusion.
Could Combining the Oxford and Sputnik V Vaccines Make Them More Effective?
The National Interest,
When the efficacy of the Oxford/AstraZeneca vaccine was announced in late 2020, there was some confusion.
Coronavirus: Here's why combining the Oxford vaccine with Russia’s Sputnik V could make it more effective
Alternet,
When the efficacy of the Oxford/AstraZeneca vaccine was announced in late 2020, there was some confusion.
Sputnik V: o que se sabe sobre a vacina que pode vir a ser usada no Brasil
O Documento,
Rafael Barifouse – Da BBC News Brasil em São Paulo Sputnik V: o que se sabe sobre a vacina da Rússia que pode vir a ser usada…
Sputnik V: o que se sabe sobre a vacina que pode vir a ser usada no Brasil
Portal MT,
Rafael Barifouse – Da BBC News Brasil em São Paulo Sputnik V: o que se sabe sobre a vacina da Rússia que pode vir a ser usada…
OP-ED: Are two vaccines better than one?
Dhaka Tribune,
Why combining the Oxford vaccine with Russias Sputnik V vaccine could make it more effective When the efficacy of the Oxford/Astr…